Medican Announces Final Approval of Acquisition Terms
Business Wire - Thu May 08, 8:02AM CDT
Medican Enterprises, Inc. (OTCBB:MDCN) a bio-pharmaceutical company focused on developing, and marketing pharmaceutical grade cannabis to the emerging global medical marijuana market is pleased to announce it has received all signatures and approvals necessary for the Amendment Agreement previously announced on May 5, 2014. This agreement sets forth the amended terms for the initial acquisition of 50% of International Herbs Medical Marijuana (IHMML).
Medican extends terms of acquisition agreement for 50% of International Herbs Medical Marijuana
M2 - Tue May 06, 5:07AM CDT
Medican Enterprises Inc (OTCBB:MDCN), a bio-pharmaceutical company focused on developing and marketing pharmaceutical grade cannabis to the medical marijuana market, announced on Monday that it has entered into an amendment agreement on 29 April 2014 which amends the terms to the subscription agreement that sets forth the terms of Medican's initial acquisition of 50% of International Herbs Medical Marijuana (IHMML).
Medican Announces Extension and Provides Update on Acquisition
Business Wire - Mon May 05, 3:42PM CDT
Medican Enterprises, Inc. (OTCBB:MDCN), a bio-pharmaceutical company focused on developing and marketing pharmaceutical grade cannabis to the emerging global medical marijuana market, announces it has entered into an amendment agreement on April 29, 2014 which amends the terms to the Subscription Agreement that sets forth the terms of its initial acquisition of 50% of International Herbs Medical Marijuana (IHMML).
CannabisFN Weekly: New Rules for Edibles Signal Maturing Market
ACCESSWIRE - Mon May 05, 8:02AM CDT
Whitefish, MT / May 5, 2014 / The Marijuana Index™ moved about 8% higher over the past week, led by a 15% jump in GW Pharmaceuticals plc (NASDAQ: GWPH) shares. Last week, Morgan Stanley analysts rated the stock "overweight" with a $103.00 per share price target, which is significantly higher than the consensus price target of $54.43. Shares of many other cannabis stocks remained largely neutral throughout the week.
Retrofit of 400,000 Square Foot Cultivation Facility
Business Wire - Mon Apr 28, 3:00PM CDT
Medican Enterprises Inc. (OTCBB: MDCN) a leading developer, distributor and marketer of pharmaceutical grade cannabis is pleased to announce its wholly owned subsidiary Canaleaf Systems Inc. through its joint venture partner International Herbs Medical Marijuana Ltd (IHMML) signed a Purchase & Sale Agreement to purchase a 400,000 square foot facility located at 12 Comeau Avenue, Atholville, NB, effective closing on May 31, 2014.
Medican Closer To Canadian MMPR with Definitive Purchase Agreement
ACCESSWIRE - Tue Apr 15, 8:05AM CDT
Whitefish, MT / April 15, 2014 / Canada's Marihuana for Medical Purposes Regulations ("MMPR"
CannabisFN Weekly: Regulatory Halts Cause Anxiety in Pot Stocks
ACCESSWIRE - Mon Apr 14, 8:04AM CDT
Whitefish, MT / April 14, 2014 / The Marijuana Index™ moved slightly lower last week amid a sell-off in the broader indices and concerns about compliance among pot stocks. Just as Advanced Cannabis Solutions Inc. (OTCBB: CANN) resumed trading, GrowLife Inc. (OTCBB: PHOT) was halted amid concerns about its disclosures and stock sales. The series of regulatory halts has led to significant anxiety among cannabis investors.
Medican Enterprises to acquire 50% of IHMML
M2 - Fri Apr 11, 7:20AM CDT
Medican Enterprises Inc (OTCBB:MDCN), a bio-pharmaceutical company operating in the medical marijuana industry, announced on Thursday that it is wholly owned subsidiary Canaleaf Systems Inc has signed a definitive purchase agreement to acquire 50% of International Herbs Medical Marijuana Ltd. (IHMML).
Medican Enterprises Inc. Signs Definitive Purchase Agreement Acquiring 50% of International Herbs Medical Marijuana Ltd.
Business Wire - Thu Apr 10, 7:01AM CDT
Medican Enterprises Inc. (OTCBB: MDCN) a bio-pharmaceutical company in the emerging global medical marijuana industry is pleased to announce its wholly owned subsidiary Canaleaf Systems Inc. (the Company) has signed a definitive purchase agreement to acquire 50 percent of International Herbs Medical Marijuana Ltd. ("IHMML"
CannabisFN Weekly: Cannabis Sector Gears Up for Canada's MMPR
ACCESSWIRE - Mon Mar 31, 8:01AM CDT
Whitefish, MT / March 31, 2014 / The Marijuana Index™ moved lower over the past week due in large part to a 40% drop in shares of Cannavest Corp. (OTCBB: CANV) along with broader declines across the sector. Many traders appeared to be locking in profits after a volatile start to 2014 although cannabis stocks showed signs of recovery during Friday's session and long-term industry catalysts like regulatory reform remain very intact.
Medican Enterprises Engages TDM Financial for Investor Communication & Marketing
ACCESSWIRE - Mon Mar 31, 7:22AM CDT
WHITEFISH, MT / ACCESSWIRE / March 31, 2014 / TDM Financial, a leading financial network covering new, emerging and established companies across many different industry verticals, today announced that Medican Enterprises, Inc. (OTCBB: MDCN) has engaged its services. Medican Enterprises is a biopharmaceutical company focused on developing, distributing and marketing pharmaceutical grade cannabis to the emerging global medical marijuana market.
Canadian National Medical Marihuana Association Welcomes Three New Industry Members
CNW Group - Fri Mar 28, 1:49PM CDT
The Canadian National Medical Marihuana Association (CNMMA) is pleased to announce Dyma Inc., Medican Enterprises, and Zenabis as its newest members.
Medican Systems Signs LOI to Acquire 50% Stake in International Herbs Medical Marijuana Ltd.
Business Wire - Wed Mar 26, 10:58AM CDT
Medican Enterprises, Inc. (OTCBB: MDCN) a bio-pharmaceutical company in the emerging global medical marijuana industry is pleased to announce its wholly owned subsidiary Medican Systems Inc. has signed a letter of intent (LOI) to purchase 50% of International Herbs Medical Marijuana Ltd. ("IHMML"
Medican Enterprises enters into Management Services agreement with International Herbs and LFG Advisory & Accounting
M2 - Wed Mar 19, 7:26AM CDT
Medican Enterprises Inc (OTCBB:MDCN), a bio-pharmaceutical company focused on pharmaceutical grade cannabis for the medical marijuana market, announced on Tuesday that the company and its subsidiaries, Medican Systems Inc and Medican (CanaLeaf) Systems Inc, have entered into an amended management service agreement with International Herbs Ltd (IHL), a fresh herbs and specialty produce company, and LFG Advisory & Accounting Ltd (LFG), an independent corporate finance and accounting advisory firm, or the consultants, effective 13 March 2014.
Medican Enterprises Signs Management Services Agreement
Business Wire - Tue Mar 18, 7:01AM CDT
Medican Enterprises Inc. (OTCBB:MDCN) ("Medican," "the Company"
Medican Enterprises names David Tobias to Advisory Board
M2 - Tue Mar 18, 4:21AM CDT
Bio-pharmaceutical company Medican Enterprises Inc (OTCBB: MDCN) announced on Monday that it has appointed David Tobias to the company's advisory board, effective 3 March 2014.
Industry Veteran David Tobias Joins Medican Enterprises Advisory Board
Business Wire - Mon Mar 17, 7:00AM CDT
Medican Enterprises, Inc. (OTCBB: MDCN) a bio-pharmaceutical company focused on developing, distributing and marketing pharmaceutical grade cannabis to the emerging global medical marijuana market is pleased to announce the appointment of David Tobias to the Company's advisory board, effective March 3, 2014.
Medican Enterprises names former New Mexico Governor Gary Johnson to the board
M2 - Thu Mar 13, 7:28AM CDT
Bio-pharmaceutical company Medican Enterprises (OTC BB:MDCN) revealed on Wednesday Gary Johnson's appointment to its board of directors effective 23 January 2014.
Medican names Gary Johnson to board
M2 - Thu Mar 13, 5:26AM CDT
Medican Enterprises Inc (OTCBB:MDCN), a bio-pharmaceutical company focused on developing, distributing and marketing pharmaceutical grade cannabis to the medical marijuana market, announced on Wednesday the appointment of Gary Johnson to its board of directors, effective 23 January 2014.
Medican Enterprises Inc. Appoints Former New Mexico Governor to the Board of Directors
Business Wire - Wed Mar 12, 7:00AM CDT
Medican Enterprises Inc. (OTCBB:MDCN) a bio-pharmaceutical company focused on developing, distributing and marketing pharmaceutical grade cannabis to the emerging global medical marijuana market is pleased to announce it has appointed Gary Johnson, a former two-term Republican governor of New Mexico, to its Board of Directors, effective January 23, 2014.